Special active pharmaceutical ingredients are bioactive chemicals used as intermediate components in pharmaceutical manufacturing, such as tablets, capsules, syrups, etc.Special active pharmaceutical ingredients include steroidal API, peptide, carbohydrate API, small molecule and high efficiency API.

Due to the COVID-19 pandemic, the global Specialty Active Pharmaceutical Ingredients market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Steroidal API accounting for % of the Specialty Active Pharmaceutical Ingredients global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While CNS segment is altered to an % CAGR throughout this forecast period.

China Specialty Active Pharmaceutical Ingredients market size is valued at US$ million in 2021, while the US and Europe Specialty Active Pharmaceutical Ingredients are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Specialty Active Pharmaceutical Ingredients landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Specialty Active Pharmaceutical Ingredients include Sanofi, Cambrex, Almac, Johnson Matthey, PolyPeptide, AmbioPharm, Avecia, ST Pharm and Biospring. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Specialty Active Pharmaceutical Ingredients Scope and Segmentt is segmented by Type and by Application. Players, stakeholders, and other participants in the global Specialty Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

By Type

Steroidal API
Peptide API
Carbohydrate API
Small Molecule API
High Potency AP

By Application

CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Rheumatology
Diabetes
Oncology
Others

By Company

Sanofi
Cambrex
Almac
Johnson Matthey
PolyPeptide
AmbioPharm
Avecia
ST Pharm
Biospring

By Region

North America
US.
Canada
Europe
Germany
France
UK.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

FEATURED COMPANIES

1 Study Coverage

1.1 Specialty Active Pharmaceutical Ingredients Product Introduction

1.2 Market by Type

1.2.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Steroidal API

1.2.3 Peptide API

1.2.4 Carbohydrate API

1.2.5 Small Molecule API

1.2.6 High Potency AP

1.3 Market by Application

1.3.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 CNS

1.3.3 Cardiovascular

1.3.4 Genitourinary/Hormonal Drugs

1.3.5 Rheumatology

1.3.6 Diabetes

1.3.7 Oncology

1.3.8 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Specialty Active Pharmaceutical Ingredients Sales Estimates and Forecasts 2017-2028

2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Estimates and Forecasts 2017-2028

2.3 Global Specialty Active Pharmaceutical Ingredients Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Specialty Active Pharmaceutical Ingredients Sales by Region

2.4.1 Global Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2022)

2.4.2 Global Sales Specialty Active Pharmaceutical Ingredients by Region (2023-2028)

2.5 Global Specialty Active Pharmaceutical Ingredients Revenue by Region

2.5.1 Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2022)

2.5.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Specialty Active Pharmaceutical Ingredients Sales by Manufacturers

3.1.1 Global Top Specialty Active Pharmaceutical Ingredients Manufacturers by Sales (2017-2022)

3.1.2 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Specialty Active Pharmaceutical Ingredients in 2021

3.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers

3.2.1 Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2017-2022)

3.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Specialty Active Pharmaceutical Ingredients Revenue in 2021

3.3 Global Specialty Active Pharmaceutical Ingredients Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Specialty Active Pharmaceutical Ingredients Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Specialty Active Pharmaceutical Ingredients Sales by Type

4.1.1 Global Specialty Active Pharmaceutical Ingredients Historical Sales by Type (2017-2022)

4.1.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Sales by Type (2023-2028)

4.1.3 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)

4.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Type

4.2.1 Global Specialty Active Pharmaceutical Ingredients Historical Revenue by Type (2017-2022)

4.2.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Revenue by Type (2023-2028)

4.2.3 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)

4.3 Global Specialty Active Pharmaceutical Ingredients Price by Type

4.3.1 Global Specialty Active Pharmaceutical Ingredients Price by Type (2017-2022)

4.3.2 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Specialty Active Pharmaceutical Ingredients Sales by Application

5.1.1 Global Specialty Active Pharmaceutical Ingredients Historical Sales by Application (2017-2022)

5.1.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Sales by Application (2023-2028)

5.1.3 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)

5.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Application

5.2.1 Global Specialty Active Pharmaceutical Ingredients Historical Revenue by Application (2017-2022)

5.2.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Revenue by Application (2023-2028)

5.2.3 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)

5.3 Global Specialty Active Pharmaceutical Ingredients Price by Application

5.3.1 Global Specialty Active Pharmaceutical Ingredients Price by Application (2017-2022)

5.3.2 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2023-2028)

6 North America

6.1 North America Specialty Active Pharmaceutical Ingredients Market Size by Type

6.1.1 North America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)

6.1.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)

6.2 North America Specialty Active Pharmaceutical Ingredients Market Size by Application

6.2.1 North America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)

6.2.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)

6.3 North America Specialty Active Pharmaceutical Ingredients Market Size by Country

6.3.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)

6.3.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Specialty Active Pharmaceutical Ingredients Market Size by Type

7.1.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)

7.1.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)

7.2 Europe Specialty Active Pharmaceutical Ingredients Market Size by Application

7.2.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)

7.2.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)

7.3 Europe Specialty Active Pharmaceutical Ingredients Market Size by Country

7.3.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)

7.3.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size by Type

8.1.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)

8.1.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)

8.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size by Application

8.2.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)

8.2.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)

8.3 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size by Region

8.3.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2028)

8.3.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Specialty Active Pharmaceutical Ingredients Market Size by Type

9.1.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)

9.1.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)

9.2 Latin America Specialty Active Pharmaceutical Ingredients Market Size by Application

9.2.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)

9.2.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)

9.3 Latin America Specialty Active Pharmaceutical Ingredients Market Size by Country

9.3.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)

9.3.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size by Type

10.1.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)

10.1.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)

10.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size by Application

10.2.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)

10.2.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)

10.3 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size by Country

10.3.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)

10.3.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Sanofi

11.1.1 Sanofi Corporation Information

11.1.2 Sanofi Overview

11.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Recent Developments

11.2 Cambrex

11.2.1 Cambrex Corporation Information

11.2.2 Cambrex Overview

11.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Cambrex Recent Developments

11.3 Almac

11.3.1 Almac Corporation Information

11.3.2 Almac Overview

11.3.3 Almac Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Almac Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Almac Recent Developments

11.4 Johnson Matthey

11.4.1 Johnson Matthey Corporation Information

11.4.2 Johnson Matthey Overview

11.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Johnson Matthey Recent Developments

11.5 PolyPeptide

11.5.1 PolyPeptide Corporation Information

11.5.2 PolyPeptide Overview

11.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 PolyPeptide Recent Developments

11.6 AmbioPharm

11.6.1 AmbioPharm Corporation Information

11.6.2 AmbioPharm Overview

11.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 AmbioPharm Recent Developments

11.7 Avecia

11.7.1 Avecia Corporation Information

11.7.2 Avecia Overview

11.7.3 Avecia Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Avecia Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Avecia Recent Developments

11.8 ST Pharm

11.8.1 ST Pharm Corporation Information

11.8.2 ST Pharm Overview

11.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 ST Pharm Recent Developments

11.9 Biospring

11.9.1 Biospring Corporation Information

11.9.2 Biospring Overview

11.9.3 Biospring Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Biospring Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Biospring Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Specialty Active Pharmaceutical Ingredients Industry Chain Analysis

12.2 Specialty Active Pharmaceutical Ingredients Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Specialty Active Pharmaceutical Ingredients Production Mode & Process

12.4 Specialty Active Pharmaceutical Ingredients Sales and Marketing

12.4.1 Specialty Active Pharmaceutical Ingredients Sales Channels

12.4.2 Specialty Active Pharmaceutical Ingredients Distributors

12.5 Specialty Active Pharmaceutical Ingredients Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Specialty Active Pharmaceutical Ingredients Industry Trends

13.2 Specialty Active Pharmaceutical Ingredients Market Drivers

13.3 Specialty Active Pharmaceutical Ingredients Market Challenges

13.4 Specialty Active Pharmaceutical Ingredients Market Restraints

14 Key Findings in The Global Specialty Active Pharmaceutical Ingredients Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Steroidal API

Table 3. Major Manufacturers of Peptide API

Table 4. Major Manufacturers of Carbohydrate API

Table 5. Major Manufacturers of Small Molecule API

Table 6. Major Manufacturers of High Potency AP

Table 7. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Specialty Active Pharmaceutical Ingredients Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 9. Global Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2022) & (K MT)

Table 10. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)

Table 11. Global Specialty Active Pharmaceutical Ingredients Sales by Region (2023-2028) & (K MT)

Table 12. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2023-2028)

Table 13. Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2022) & (US$ Million)

Table 14. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2017-2022)

Table 15. Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2023-2028) & (US$ Million)

Table 16. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2023-2028)

Table 17. Global Specialty Active Pharmaceutical Ingredients Sales by Manufacturers (2017-2022) & (K MT)

Table 18. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2017-2022)

Table 19. Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 20. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2017-2022)

Table 21. Specialty Active Pharmaceutical Ingredients Price by Manufacturers (2017-2022) &(USD/MT)

Table 22. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2021)

Table 24. Specialty Active Pharmaceutical Ingredients Manufacturing Base Distribution and Headquarters

Table 25. Manufacturers Specialty Active Pharmaceutical Ingredients Product Offered

Table 26. Date of Manufacturers Enter into Specialty Active Pharmaceutical Ingredients Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 29. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)

Table 30. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2017-2022)

Table 31. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2023-2028)

Table 32. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)

Table 33. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)

Table 34. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2017-2022)

Table 35. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2023-2028)

Table 36. Specialty Active Pharmaceutical Ingredients Price by Type (2017-2022) & (USD/MT)

Table 37. Global Specialty Active Pharmaceutical Ingredients Price Forecast by Type (2023-2028) & (USD/MT)

Table 38. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 39. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)

Table 40. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2017-2022)

Table 41. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2023-2028)

Table 42. Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)

Table 43. Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)

Table 44. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Application (2017-2022)

Table 45. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Application (2023-2028)

Table 46. Specialty Active Pharmaceutical Ingredients Price by Application (2017-2022) & (USD/MT)

Table 47. Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2023-2028) & (USD/MT)

Table 48. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 49. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)

Table 50. North America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)

Table 51. North America Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)

Table 52. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 53. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)

Table 54. North America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)

Table 55. North America Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)

Table 56. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)

Table 57. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)

Table 58. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)

Table 59. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)

Table 60. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 61. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)

Table 62. Europe Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)

Table 63. Europe Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)

Table 64. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 65. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)

Table 66. Europe Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)

Table 67. Europe Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)

Table 68. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)

Table 69. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)

Table 70. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)

Table 71. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)

Table 72. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 73. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)

Table 74. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)

Table 75. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)

Table 76. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 77. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)

Table 78. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)

Table 79. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)

Table 80. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2022) & (K MT)

Table 81. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2023-2028) & (K MT)

Table 82. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2022) & (US$ Million)

Table 83. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2023-2028) & (US$ Million)

Table 84. Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 85. Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)

Table 86. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)

Table 87. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)

Table 88. Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 89. Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)

Table 90. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)

Table 91. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)

Table 92. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)

Table 93. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)

Table 94. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)

Table 95. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)

Table 96. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 97. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)

Table 98. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)

Table 99. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)

Table 100. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 101. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)

Table 102. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)

Table 103. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)

Table 104. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)

Table 105. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)

Table 106. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)

Table 107. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)

Table 108. Sanofi Corporation Information

Table 109. Sanofi Description and Major Businesses

Table 110. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 111. Sanofi Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Sanofi Recent Developments

Table 113. Cambrex Corporation Information

Table 114. Cambrex Description and Major Businesses

Table 115. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 116. Cambrex Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Cambrex Recent Developments

Table 118. Almac Corporation Information

Table 119. Almac Description and Major Businesses

Table 120. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 121. Almac Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Almac Recent Developments

Table 123. Johnson Matthey Corporation Information

Table 124. Johnson Matthey Description and Major Businesses

Table 125. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 126. Johnson Matthey Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Johnson Matthey Recent Developments

Table 128. PolyPeptide Corporation Information

Table 129. PolyPeptide Description and Major Businesses

Table 130. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 131. PolyPeptide Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. PolyPeptide Recent Developments

Table 133. AmbioPharm Corporation Information

Table 134. AmbioPharm Description and Major Businesses

Table 135. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 136. AmbioPharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. AmbioPharm Recent Developments

Table 138. Avecia Corporation Information

Table 139. Avecia Description and Major Businesses

Table 140. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 141. Avecia Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Avecia Recent Developments

Table 143. ST Pharm Corporation Information

Table 144. ST Pharm Description and Major Businesses

Table 145. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 146. ST Pharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. ST Pharm Recent Developments

Table 148. Biospring Corporation Information

Table 149. Biospring Description and Major Businesses

Table 150. Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 151. Biospring Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Biospring Recent Developments

Table 153. Key Raw Materials Lists

Table 154. Raw Materials Key Suppliers Lists

Table 155. Specialty Active Pharmaceutical Ingredients Distributors List

Table 156. Specialty Active Pharmaceutical Ingredients Customers List

Table 157. Specialty Active Pharmaceutical Ingredients Market Trends

Table 158. Specialty Active Pharmaceutical Ingredients Market Drivers

Table 159. Specialty Active Pharmaceutical Ingredients Market Challenges

Table 160. Specialty Active Pharmaceutical Ingredients Market Restraints

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Specialty Active Pharmaceutical Ingredients Product Picture

Figure 3. Global Specialty Active Pharmaceutical Ingredients Market Share by Type in 2021 & 2028

Figure 3. Steroidal API Product Picture

Figure 4. Peptide API Product Picture

Figure 5. Carbohydrate API Product Picture

Figure 6. Small Molecule API Product Picture

Figure 7. High Potency AP Product Picture

Figure 8. Global Specialty Active Pharmaceutical Ingredients Market Share by Application in 2021 & 2028

Figure 9. CNS

Figure 10. Cardiovascular

Figure 11. Genitourinary/Hormonal Drugs

Figure 12. Rheumatology

Figure 13. Diabetes

Figure 14. Oncology

Figure 15. Others

Figure 16. Specialty Active Pharmaceutical Ingredients Report Years Considered

Figure 17. Global Specialty Active Pharmaceutical Ingredients Sales 2017-2028 (K MT)

Figure 18. Global Specialty Active Pharmaceutical Ingredients Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 19. Global Specialty Active Pharmaceutical Ingredients Revenue 2017-2028 (US$ Million)

Figure 20. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 21. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)

Figure 22. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2023-2028)

Figure 23. North America Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)

Figure 24. North America Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Europe Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)

Figure 26. Europe Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)

Figure 27. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)

Figure 28. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)

Figure 29. Latin America Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)

Figure 30. Latin America Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)

Figure 31. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)

Figure 32. Middle East & Africa Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)

Figure 33. The Specialty Active Pharmaceutical Ingredients Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 34. The Top 5 and 10 Largest Manufacturers of Specialty Active Pharmaceutical Ingredients in the World: Market Share by Specialty Active Pharmaceutical Ingredients Revenue in 2021

Figure 35. Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 36. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)

Figure 37. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)

Figure 38. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)

Figure 39. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)

Figure 40. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)

Figure 41. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)

Figure 42. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)

Figure 43. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)

Figure 44. North America Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)

Figure 45. North America Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)

Figure 46. U.S. Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 47. Canada Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 48. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)

Figure 49. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)

Figure 50. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)

Figure 51. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)

Figure 52. Europe Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)

Figure 53. Europe Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)

Figure 54. Germany Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 55. France Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 56. U.K. Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 57. Italy Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 58. Russia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 59. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)

Figure 60. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)

Figure 61. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)

Figure 62. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)

Figure 63. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Share by Region (2017-2028)

Figure 64. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Share by Region (2017-2028)

Figure 65. China Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 66. Japan Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 67. South Korea Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 68. India Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 69. Australia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 70. Taiwan Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 71. Indonesia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 72. Thailand Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 73. Malaysia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 74. Philippines Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 75. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)

Figure 76. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)

Figure 77. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)

Figure 78. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)

Figure 79. Latin America Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)

Figure 80. Latin America Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)

Figure 81. Mexico Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 82. Brazil Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 83. Argentina Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 84. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)

Figure 85. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)

Figure 86. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)

Figure 87. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)

Figure 88. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)

Figure 89. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)

Figure 90. Turkey Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 91. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 92. U.A.E Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)

Figure 93. Specialty Active Pharmaceutical Ingredients Value Chain

Figure 94. Specialty Active Pharmaceutical Ingredients Production Process

Figure 95. Channels of Distribution

Figure 96. Distributors Profiles

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation

Figure 99. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Specialty Active Pharmaceutical Ingredients Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-14S833

Global Specialty Active Pharmaceutical Ingredients Market Insights, Forecast to 2028

FEATURED COMPANIES

Special Active Pharmaceutical Ingredients Market

By Type

By Application

By Company

By Region

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31X6782

Fri May 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-7E13021

Fri May 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-20G6893

Fri May 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-34Y12560

Fri May 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions